UniProtKB/Swiss-Prot P02462: Variant p.Met1531Val

Collagen alpha-1(IV) chain
Gene: COL4A1
Feedback?

Variant information Variant position:

1531 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Methionine (M) to Valine (V) at position 1531 (M1531V, p.Met1531Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1343193102 [ dbSNP | Ensembl ]

Sequence information Variant position:

1531 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1669 The length of the canonical sequence.
Location on the sequence:

CNFASRNDYSYWLSTPEPMP M SMAPITGENIRPFISRCAVC The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         CNFASRNDYSYWLSTPEPMPMSMAPITGENIRPFISRCAVC

Mouse                         CNFASRNDYSYWLSTPEPMPMSMAPISGDNIRPFISRCAVC

Bovine                        CNFASRNDYSYWLSTPEPMPMSMAPITGENIRPFISRCAVC

Caenorhabditis elegans        CHVSSRNDYSFWLSTDEPMTPMMNPVTGTAIRPYISRCAVC

Drosophila                    CNYASRNDKTFWLTTNAAIP--MMPVENIEIRQYISRCVVC

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	173 – 1669	Collagen alpha-1(IV) chain
Chain	1445 – 1669	Arresten
Domain	1445 – 1669	Collagen IV NC1
Disulfide bond	1460 – 1551
Disulfide bond	1493 – 1548
Cross	1533 – 1533	S-Lysyl-methionine sulfilimine (Met-Lys) (interchain with K-1651)
Alternative sequence	520 – 1669	Missing. In isoform 2.

Literature citations
COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage.
Weng Y.C.; Sonni A.; Labelle-Dumais C.; de Leau M.; Kauffman W.B.; Jeanne M.; Biffi A.; Greenberg S.M.; Rosand J.; Gould D.B.;
Ann. Neurol. 71:470-477(2012)
Cited for: INVOLVEMENT IN ICH; VARIANTS ICH LEU-352 AND GLY-538; VARIANTS VAL-144 AND VAL-1531; CHARACTERIZATION OF VARIANTS ICH LEU-352 AND GLY-538;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.